Advertisement
Screener

TFF PHARMACEUTICALS, INC. Stock-Based Compensation

TFF PHARMACEUTICALS, INC. Stock-Based Compensation

TFF PHARMACEUTICALS, INC. reported Stock-Based Compensation of $1.80 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2024-11-20

  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $567.67K, a 25.92% decline year-over-year.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-06-30 was $608.35K, a 26.32% decline year-over-year.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-03-31 was $626.99K, a 16.60% decline year-over-year.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $582.43K, a 36.93% decline year-over-year.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $2.93M, a 31.18% decline from fiscal 2022.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.25M, a 19.83% increase from fiscal 2021.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $3.55M, a 62.24% increase from fiscal 2020.
  • TFF PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $2.19M, a 270.68% increase from fiscal 2019.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 8 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 11 monthShare-based Payment Arrangement, Noncash Expense 12 month
2024-09-30$567.67K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20
$1.18M
derived: sum of 2 quarters · filed 2024-11-20
$1.80M
10-Q · filed 2024-11-20
$2.39M
derived: sum of 4 quarters · filed 2024-11-20
2024-06-30$608.35K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$1.24M
10-Q · filed 2024-08-14
$1.82M
derived: sum of 3 quarters · filed 2024-08-14
$2.58M
derived: sum of 4 quarters · filed 2024-11-20
2024-03-31$626.99K
10-Q · filed 2024-05-14
$1.21M
derived: sum of 2 quarters · filed 2024-05-14
$1.98M
derived: sum of 3 quarters · filed 2024-11-20
$2.80M
derived: sum of 4 quarters · filed 2024-11-20
2023-12-31$582.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$1.35M
derived: sum of 2 quarters · filed 2024-11-20
$2.17M
derived: sum of 3 quarters · filed 2024-11-20
$2.93M
10-K · filed 2024-03-28
2023-09-30$766.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20
$1.59M
derived: sum of 2 quarters · filed 2024-11-20
$2.34M
10-Q · filed 2024-11-20
$3.27M
derived: sum of 4 quarters · filed 2024-11-20
2023-06-30$825.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$1.58M
10-Q · filed 2024-08-14
$2.50M
derived: sum of 3 quarters · filed 2024-08-14
$3.46M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$751.82K
10-Q · filed 2024-05-14
$1.68M
derived: sum of 2 quarters · filed 2024-05-14
$2.63M
derived: sum of 3 quarters · filed 2024-05-14
$3.83M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$923.49K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$1.88M
derived: sum of 2 quarters · filed 2024-03-28
$3.07M
derived: sum of 3 quarters · filed 2024-03-28
$4.25M
10-K · filed 2024-03-28
2022-09-30$955.56K
10-Q · filed 2022-11-14
$2.15M
derived: sum of 2 quarters · filed 2022-11-14
$3.33M
10-Q · filed 2023-11-14
2022-06-30$1.20M
10-Q · filed 2022-11-14
$2.37M
10-Q · filed 2023-08-14
2022-03-31$1.18M
10-Q · filed 2023-05-11
2021-12-31$3.55M
10-K · filed 2023-03-31
2021-09-30$856.59K
10-Q · filed 2022-11-14
$1.60M
derived: sum of 2 quarters · filed 2022-11-14
$2.63M
derived: sum of 3 quarters · filed 2022-11-14
$3.55M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$740.53K
10-Q · filed 2022-11-14
$1.77M
derived: sum of 2 quarters · filed 2022-11-14
$2.69M
derived: sum of 3 quarters · filed 2022-11-14
$3.24M
derived: sum of 4 quarters · filed 2022-11-14
2021-03-31$1.03M
10-Q · filed 2022-11-14
$1.95M
derived: sum of 2 quarters · filed 2022-11-14
$2.50M
derived: sum of 3 quarters · filed 2022-11-14
$2.79M
derived: sum of 4 quarters · filed 2022-11-14
2020-12-31$919.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$1.47M
derived: sum of 2 quarters · filed 2022-03-24
$1.76M
derived: sum of 3 quarters · filed 2022-03-24
$2.19M
10-K · filed 2022-03-24
2020-09-30$546.12K
10-Q · filed 2021-11-15
$841.48K
derived: sum of 2 quarters · filed 2021-11-15
$1.27M
10-Q · filed 2020-11-05
$1.48M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$295.36K
10-Q · filed 2021-11-15
$721.20K
10-Q · filed 2020-08-13
$932.63K
derived: sum of 3 quarters · filed 2021-11-15
$703.62K
derived: sum of 4 quarters · filed 2021-11-15
2020-03-31$425.84K
10-Q · filed 2021-11-15
$637.28K
derived: sum of 2 quarters · filed 2021-11-15
$408.26K
derived: sum of 3 quarters · filed 2021-11-15
$894.66K
derived: sum of 4 quarters · filed 2021-11-15
2019-12-31$211.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
-$17.58K
derived: sum of 2 quarters · filed 2021-03-10
$468.81K
derived: sum of 3 quarters · filed 2021-03-10
$590.04K
10-K · filed 2021-03-10
2019-09-30-$229.02K
10-Q · filed 2020-11-05
$257.38K
derived: sum of 2 quarters · filed 2020-11-05
$378.61K
10-Q · filed 2020-11-05
2019-06-30$486.40K
10-Q · filed 2020-08-13
$607.62K
10-Q · filed 2020-08-13
2019-03-31$121.23K
10-Q · filed 2020-05-14
2018-12-31$1.33M
10-K · filed 2020-03-27
2018-09-30$62.11K
10-Q · filed 2019-12-09
$1.24M
10-Q · filed 2019-12-09
$1.24M
10-Q · filed 2019-12-09